Tag: vaccine

In the News: Join leading medical & business experts for June 22 pandemic innovation conference

Speakers announced for the upcoming OurCrowd Pandemic Innovation Conference on Monday, June 22; to name a few: Dr. Paul Rothman, CEO, Johns Hopkins Medicine Professor Joseph M. Jacobson, Head, MIT Molecular Machines Research Group Dr. Ruth Atherton, Director, Bill & Melinda Gates Foundation Sigal Kremer-Tal, MD, Chief Clinical and Regulatory Officer, MigVax (leading vaccine startup) See more featured speakers, plus agenda preview. The online conference will explore the latest technological solutions to the coronavirus crisis, including vaccination, treatment, diagnostics and prevention of the disease. The sessions will also cover non-healthcare innovations addressing the changing nature of work and life brought about by the ‘Pandemic Pivot’ occurring in the global economy.  Top Tech News Insurtech leader Lemonade files for an IPO in New York, targeting $100 million. More great news from leading Israeli coronavirus vaccine developer MigVax – welcome to the Board of Directors, Eyal Desheh (previously CFO of leading Israeli companies Check Point and Teva Pharmaceuticals). MagniLEARN, another emerging star from Labs/02: The Israeli method that could teach China to speak English.  Shouldn’t there be better tools and technology today to know what...

Read More

In the News: Hand sanitizer for the nose? Trials for new COVID-19 treatment

How are breakthrough technologies overcoming coronavirus challenges – from prevention and cure to social distancing and food supply? What will the tech investing world look like in the future? Join us as we bring together the global tech ecosystem – online, and address these topics on June 22nd at the OurCrowd Pandemic Innovation Conference, which will be streamed twice to accommodate global participants. Register now. You’ve used hand sanitizer – can a ‘hand sanitizer for the nose’ be next? Watch this CTV news feature about the potential COVID-19 “game-changer” by SaNOtize, and the Phase II trials of the company’s nitric oxide nasal spray to determine if it can kill the virus in the upper airway before it can spread to the lungs. CTV News reports: “If the trial shows SaNOtize reduces the symptoms and duration of COVID-19 and it’s approved by Health Canada, the company hopes it can be sold at pharmacies until a vaccine is found.” We’re re-investing in SaNOtize now – learn more. Top Tech News Trying to sell your car? Read 3 tips and 1 way to...

Read More

Latest from Twitter